Wh. Westra et al., SQUAMOUS-CELL GRANULOMAS OF THE NECK - HISTOLOGIC REGRESSION OF METASTATIC SQUAMOUS-CELL CARCINOMA FOLLOWING CHEMOTHERAPY AND OR RADIOTHERAPY/, Head & neck, 20(6), 1998, pp. 515-521
Background For patients with squamous cell carcinoma of the head and n
eck (HNSCC), persistence of cervical adenopathy following organ-preser
vation therapy is a strong predictor of locoregional failure. Squamous
cell granulomas of the neck may represent a regressed state of metast
atic HNSCC; however, relevant clinicopathologic features of this lesio
n including its morphologic characteristics, association with therapy,
and relationship to disease progression are not well defined. Methods
. We reviewed 866 consecutive neck dissections performed at The Johns
Hopkins Hospital from 1984 to 1996. A total of eight cases showing a f
oreign-body giant-cell reaction to keratin in the absence of viable tu
mor formed the basis of this study. Results. All eight cases were from
patients with stage III or IV HNSCC with concurrent neck masses. Pati
ents were initially treated by chemotherapy (n = 1), radiotherapy (n =
1), or chemotherapy plus radiotherapy (n = 6); and all patients subse
quently underwent neck dissection for persistence of their neck masses
. Histologically, the neck lesions were characterized by a foreign-bod
y giant-cell reaction to keratin and extensive scarring. None (0%) of
the patients developed recurrent regional disease in the treated neck.
Two (25%) of the patients had tumor recurrence at the primary site. T
wo (25%) of the patients developed widely metastatic disease. Conclusi
ons. These observations suggest that squamous cell granulomas represen
t histologic regression of metastatic squamous cell carcinoma in patie
nts with HNSCC treated by chemotherapy and/or radiotherapy. Although p
ersistent cervical adenopathy is an established risk factor for locore
gional failure in this group of patients, squamous cell granulomas of
the neck paradoxically may reflect enhanced regional tumor sensitivity
to cytotoxic agents. (C) 1998 John Wiley & Sons, Inc.